Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
These innovations not only enhance therapeutic outcomes but also pave the way for sustainable, patient-centric healthcare solutions (115, 116)
While CBP/p300 is a well-validated direct interaction partner of NRF2 with prominent functions at enhancers, we report that this interaction is not required for NRF2-dependent NSCLC cell growth, indicating that NRF2 can sustain sufficient transcriptional activity in the absence of CBP/p300 coactivation
Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population - results from the PolSenior substudy
Li, B., Carey, M
Danhong injection modulates microglial polarization and neuroinflammation via the JUNB/NF-kappaB pathway in ischemic stroke
Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy
